Skip to main content
. 2019 May 9;3(2):31–71. doi: 10.1159/000500413

Fig. 11.

Fig. 11

Decentralized clinical trials. There are two components to consider to determine the level of decentralization in a clinical trial: whether the data are captured at a site or near the patient (e.g., location), and how the data are captured (e.g., manually or digitally).